Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Kymera Therapeutics: Q1 Earnings Insights

 

Kymera Therapeutics (NASDAQ:KYMR) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Kymera Therapeutics missed estimated earnings by 7.58%, reporting an EPS of $-0.71 versus an estimate of $-0.66.

Revenue was down $9.08 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.09 which was followed by a 1.86% increase in the share price the next day.

 

To track all earnings releases for Kymera Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.